Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
26-WEEK TRIAL Clinical Trial Identifier: NCT02580591 Trial name: Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients with T1DM (EASE-3) Diabetes type: Type 1 diabetes What its testing: This trial will assess the efficacy, safety, tolerability, and pharmacokinetics (how a drug is metabolized by the body) of three doses of Jardiance as a supplement to insulin in people with type 1 diabetes
& Tsukamoto, H
Zhao et al., 2021a
By tracking them, you can ensure your gastrointestinal system stays strong during treatment
Cell Mol Life Sci 57 : 932942 Werner H, Shalita-Chesner M, Abramovitch S, Idelman G, Shaharabani-Gargir L, Glaser T (2000) Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer
You do need a valid prescription from a licensed clinician
US$ 28.57
US$ 29.60
US$ 22.50
US$ 23.83
US$ 20.39
US$ 28.41
